SON

Aira Technologies develops world's first AI-based channel estimation and prediction xApp and is awarded Telecom Infrastructure Project "Silver Badge"

Retrieved on: 
Monday, April 8, 2024

SARATOGA, Calif., April 8, 2024 /PRNewswire-PRWeb/ -- Aira Technologies, a pioneer in the application of Artificial Intelligence (AI) and Machine Learning (ML) to radically improve wireless telecommunications, today announced that it has been awarded a Silver Badge from the Telecom Infrastructure Project (TIP), for delivering an AI-based High Fidelity MIMO Channel Estimation and Prediction application (UC2 xApp). The requirements of the UC2 xApp have been specified by the RAN Intelligence & Automation (RIA) subgroup of the TIP OpenRAN Project Group.

Key Points: 
  • The requirements of the UC2 xApp have been specified by the RAN Intelligence & Automation (RIA) subgroup of the TIP OpenRAN Project Group.
  • "Aira's xApp delivers against this need by providing high-fidelity beam management through improved channel estimation and prediction.
  • The Aira AI-based High Fidelity MIMO Channel Estimation and Prediction xApp ran atop the RIC.
  • "Benchmarking and testing of RIC xApp performance under realistic channel conditions is crucial for gaining operator acceptance.

iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

Retrieved on: 
Thursday, February 15, 2024

BOSTON, Feb. 14, 2024 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that New Drug Part has secured a potent anti-cancer candidate, PHAGERIA®, with broad antimicrobial activity against ETBF (Enterotoxigenic B. fragilis), a harmful microbe associated with colorectal cancer.

Key Points: 
  • iNtRON stated that following the proprietary development of the Robot Bacteriophage 2nd generation technology, additional in-vitro evolution technology was applied.
  • The Company previously secured the technology to customize and edit bacteriophage genomes as desired using tailored CRISPR/Cas technology and Random Transposon Mutagenesis in 2022.
  • Recently, the Company has advanced this technology further to develop a more potent anti-cancer candidate, PHAGERIA®.
  • This achievement is significant as it is the first instance of applying in-vitro Evolution technology to ETBF bacteriophages, demonstrating the excellence of the bacteriophage gene editing technology (CRISPR/Cas) and Robotic Bacteriophage improvement platform technology of the Company.

AirHop Announces Organizational Changes to Support Global Growth

Retrieved on: 
Tuesday, December 19, 2023

AirHop Communications , the leading provider of Open RAN (Radio Access Network) Automation and Optimization software for 4G and 5G networks, has announced key organizational changes to support its continued growth objectives.

Key Points: 
  • AirHop Communications , the leading provider of Open RAN (Radio Access Network) Automation and Optimization software for 4G and 5G networks, has announced key organizational changes to support its continued growth objectives.
  • Anand Parikh has been appointed as the new Chief Executive Officer (CEO) of AirHop, effective immediately.
  • These changes will facilitate AirHop’s increasing commercial deployments and revenue growth in 2024 and beyond.
  • Anand, formerly VP of Strategic Partnerships at AirHop, is an entrepreneurial leader with over 35 years of success in high-tech companies.

THE CENTER FOR DISCOVERY CEO PATRICK H. DOLLARD TO MOVE INTO SENIOR ADVISORY ROLE IN THE NEW YEAR

Retrieved on: 
Monday, October 16, 2023

HARRIS, N.Y., Oct. 16, 2023 /PRNewswire/ -- THE CENTER FOR DISCOVERY® (TCFD) TODAY ANNOUNCED THAT CHIEF EXECUTIVE OFFICER PATRICK H. DOLLARD, WHO HAS LED THE ORGANIZATION FOR 43 YEARS, HAS DECIDED TO TRANSITION INTO A NEW ROLE AS SENIOR ADVISOR. THE BOARD OF DIRECTORS IMMEDIATELY NAMED DR. THERESA HAMLIN, ITS PRESIDENT, TO SUCCEED HIM. THE CHANGES ARE EFFECTIVE AT THE START OF THE NEW YEAR. 

Key Points: 
  • I HAVE REALLY ENJOYED WORKING CLOSELY WITH HIM OVER THIS PAST DECADE AND THE BOARD IS DELIGHTED HE WILL CONTINUE TO SERVE AS A SENIOR ADVISOR.
  • AS PATRICK TRANSITIONS INTO A SENIOR ADVISORY ROLE, WE ARE FORTUNATE TO HAVE DR. THERESA HAMLIN ASSUME THE CEO POSITION AT THE START OF THE NEW YEAR."
  • "TODAY TCFD IS RECOGNIZED AS A NATIONAL CENTER OF EXCELLENCE THANKS TO PATRICK'S ADVOCACY AND THOUGHT LEADERSHIP OVER FOUR DECADES.
  • "WE ARE GRATEFUL TO PATRICK FOR HIS BOLD VISION AND LEADERSHIP, AND FORTUNATE TO HAVE SOMEONE AS QUALIFIED, ENTHUSIASTIC AND READY FOR THE FUTURE AS TERRY."

PEPSI MAX® TEAMS UP WITH EA SPORTS FC™ TO PROVIDE FANS WITH IN-GAME ULTIMATE TEAM™ REWARDS

Retrieved on: 
Thursday, October 5, 2023

NEW YORK, Oct. 5, 2023 /PRNewswire/ -- Today, Pepsi MAX® and EA SPORTS FC™ have revealed details of an epic international campaign that will elevate gamers' experiences of the hotly anticipated new football game, EA SPORTS FC™ 24. The partnership is fronted by three world-class footballers, consisting of an on-pack promotion that allows fans to receive in-game rewards by simply purchasing participating Pepsi MAX products.

Key Points: 
  • The partnership is fronted by three world-class footballers, consisting of an on-pack promotion that allows fans to receive in-game rewards by simply purchasing participating Pepsi MAX products.
  • By purchasing a promotional Pepsi MAX can or bottle, fans will be able to redeem EA SPORTS FC™ 24 Ultimate Team™ in-game rewards, including one Ultimate Team™ 75+ rated untradeable gold item, enabling players to build formidable player line-ups within the new game.
  • The cans and bottles also provide access to slick vanity rewards including Pepsi football kits, attractive stadium designs and TIFO's - all redeemable via gaming console* or PC.
  • The spot shows the Brazilian baller taking shots against goal before the ball slams against a Pepsi vending machine, releasing several limited-edition Pepsi MAX x EA SPORTS FC™ 24 cans and Vini's subsequent EA SPORTS FC™ 24 rewards.

GlobalLogic Acquires Sidero, a Leading Software Engineering Firm in Ireland

Retrieved on: 
Monday, July 10, 2023

This strategic acquisition aims to bolster GlobalLogic's capabilities in the dynamic Communications technology sector, and expands its European presence in Ireland.

Key Points: 
  • This strategic acquisition aims to bolster GlobalLogic's capabilities in the dynamic Communications technology sector, and expands its European presence in Ireland.
  • Sidero's talented experience design and engineering teams based in Athlone, Republic of Ireland & Newry, Northern Ireland, facilitate the creation of innovative solutions that will directly benefit GlobalLogic’s current and future clients.
  • “We are thrilled to welcome the talented Sidero team into the GlobalLogic family.” said Nitesh Banga, President and CEO of GlobalLogic.
  • Under the agreement, Sidero will continue to operate with its existing leadership and staff as a wholly owned subsidiary of GlobalLogic.

Government of Canada teams up with Indigenous partners, Bruce Power and the medical isotope community to fight cancer

Retrieved on: 
Tuesday, June 27, 2023

The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.

Key Points: 
  • The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.
  • This funding will ultimately enable a pan-Canadian consortium – the Canadian Medical Isotope Ecosystem (CMIE) – to advance and accelerate the development of the next generation of novel medical isotopes and technologies.
  • “Canada is a world leader in medical isotope research and production, and Bruce Power is proud to be among the innovative companies that places Canada at the forefront of nuclear medicine,” said Mike Rencheck, Bruce Power’s President and CEO.
  • “Our government is proud to partner in the creation of the Canadian Medical Isotope Ecosystem, which includes support for the SON First Nations communities’ partnership with Bruce Power to innovate in the fight against cancer,” said Minister Champagne.

Government strengthens Canada's leadership role in medical isotope production

Retrieved on: 
Tuesday, June 27, 2023

Canada has played a key leadership role in the development and use of medical isotopes for over 70 years, positioning the country as a global leader in the production and supply of medical isotopes.

Key Points: 
  • Canada has played a key leadership role in the development and use of medical isotopes for over 70 years, positioning the country as a global leader in the production and supply of medical isotopes.
  • This funding responds to the Canadian Nuclear Isotope Council's report, Isotopes for Hope: Canadian Leadership Needed Now More Than Ever, calling on the federal government to invest in the growth of Canada's medical isotope ecosystem.
  • The Canadian Medical Isotope Ecosystem will play a crucial role in the development and distribution of medical isotopes and radiopharmaceuticals across the country.
  • The new Canadian Medical Isotope Ecosystem brings together government, industry and academia to work collaboratively to build Canadian medical isotope capabilities and ensure Canada remains a leader in this high-growth sector."

iNtRON identifies Prophage and Jamphage in the Pancreatic cancer related Microbiome

Retrieved on: 
Tuesday, May 30, 2023

BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com ) has announced today the identification of Prophage and (non-) ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.

Key Points: 
  • BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com ) has announced today the identification of Prophage and (non-) ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.
  • The ultimate goal is to develop phage-based immunotherapeutics capable of treating a range of immune disorders including cancer.
  • The primary focus of the company lies in Colorectal cancer and Pancreatic cancer.
  • Alkalihalobacillus clausii has been identified as a representative microbiome, and iNtRON has obtained the strain and confirmed the presence of Prophage and Jamphage through the genomic analysis.

Winbond Sets Global Sustainability Standard with Sustainability Initiatives and Products

Retrieved on: 
Wednesday, April 26, 2023

TAICHUNG, Taiwan, April 26, 2023 /PRNewswire/ -- Winbond Electronics Corporation, a leading global supplier of semiconductor memory solutions, today announced the results of its sustainability performance along with aggressive goals and product development plans to expand that leadership in 2023. In addition to its many corporate Environmental Social and Governance (ESG) goals and initiatives, Winbond has also demonstrated its commitment to sustainability through its product development, including flash memory products that support low temperature soldering (LTS) process, space saving techniques used in 100BGA LPDDR4/4X, and advancements in ultra-low power consumption.

Key Points: 
  • Winbond is taking additional actions this year in the following areas to achieve specific goals by 2030 and 2050.
  • Ultra-Low Power Consumption – Winbond made several announcements designed to drive ultra-low power consumption in its flash memory products.
  • Secure Flash - Winbond is innovating security in memory for more ethical products and more effortless privacy protection in its customers' products.
  • As a result of its sustainability performance over the last year, Winbond received a number of industry awards and accolades.